GlobeNewswire Inc.··Pomerantz LlpImmunityBio Faces Class Action Over FDA Warning Letter; Stock Plummets 21%
Pomerantz Law Firm files class action lawsuit against $IBRX over FDA warning letter regarding misleading cancer drug promotion, triggering sharp stock decline.
VITLIBRXNUAINUAIWsecurities fraudclass action lawsuit